Logo image of HLMN

HILLMAN SOLUTIONS CORP (HLMN) Stock Fundamental Analysis

NASDAQ:HLMN - Nasdaq - US4316361090 - Common Stock - Currency: USD

7.52  +0.13 (+1.76%)

After market: 7.5 -0.02 (-0.27%)

Fundamental Rating

4

Taking everything into account, HLMN scores 4 out of 10 in our fundamental rating. HLMN was compared to 128 industry peers in the Machinery industry. HLMN has a medium profitability rating, but doesn't score so well on its financial health evaluation. HLMN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year HLMN was profitable.
In the past year HLMN had a positive cash flow from operations.
In the past 5 years HLMN reported 4 times negative net income.
HLMN had a positive operating cash flow in 4 of the past 5 years.
HLMN Yearly Net Income VS EBIT VS OCF VS FCFHLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.79%, HLMN is doing worse than 65.63% of the companies in the same industry.
The Return On Equity of HLMN (1.56%) is worse than 64.84% of its industry peers.
The Return On Invested Capital of HLMN (2.72%) is worse than 67.19% of its industry peers.
HLMN had an Average Return On Invested Capital over the past 3 years of 1.94%. This is significantly below the industry average of 10.71%.
The last Return On Invested Capital (2.72%) for HLMN is above the 3 year average (1.94%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.79%
ROE 1.56%
ROIC 2.72%
ROA(3y)-0.11%
ROA(5y)-0.56%
ROE(3y)-0.26%
ROE(5y)-2.17%
ROIC(3y)1.94%
ROIC(5y)1.62%
HLMN Yearly ROA, ROE, ROICHLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

The Profit Margin of HLMN (1.24%) is worse than 63.28% of its industry peers.
HLMN's Operating Margin of 5.91% is in line compared to the rest of the industry. HLMN outperforms 40.63% of its industry peers.
HLMN's Operating Margin has improved in the last couple of years.
HLMN has a Gross Margin of 47.90%. This is amongst the best in the industry. HLMN outperforms 90.63% of its industry peers.
HLMN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.91%
PM (TTM) 1.24%
GM 47.9%
OM growth 3Y102.86%
OM growth 5Y36.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.57%
GM growth 5Y2.32%
HLMN Yearly Profit, Operating, Gross MarginsHLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HLMN is destroying value.
Compared to 1 year ago, HLMN has more shares outstanding
HLMN has more shares outstanding than it did 5 years ago.
HLMN has a better debt/assets ratio than last year.
HLMN Yearly Shares OutstandingHLMN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
HLMN Yearly Total Debt VS Total AssetsHLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

HLMN has an Altman-Z score of 1.58. This is a bad value and indicates that HLMN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of HLMN (1.58) is worse than 74.22% of its industry peers.
The Debt to FCF ratio of HLMN is 8.77, which is on the high side as it means it would take HLMN, 8.77 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of HLMN (8.77) is comparable to the rest of the industry.
HLMN has a Debt/Equity ratio of 0.60. This is a neutral value indicating HLMN is somewhat dependend on debt financing.
HLMN has a Debt to Equity ratio of 0.60. This is in the lower half of the industry: HLMN underperforms 61.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 8.77
Altman-Z 1.58
ROIC/WACC0.3
WACC9.12%
HLMN Yearly LT Debt VS Equity VS FCFHLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

HLMN has a Current Ratio of 2.46. This indicates that HLMN is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.46, HLMN is doing good in the industry, outperforming 64.06% of the companies in the same industry.
A Quick Ratio of 0.79 indicates that HLMN may have some problems paying its short term obligations.
HLMN has a Quick ratio of 0.79. This is in the lower half of the industry: HLMN underperforms 75.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 0.79
HLMN Yearly Current Assets VS Current LiabilitesHLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.18% over the past year.
Looking at the last year, HLMN shows a small growth in Revenue. The Revenue has grown by 0.31% in the last year.
HLMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.93% yearly.
EPS 1Y (TTM)18.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)0.31%
Revenue growth 3Y1.08%
Revenue growth 5Y3.93%
Sales Q2Q%2.58%

3.2 Future

The Earnings Per Share is expected to grow by 14.19% on average over the next years. This is quite good.
HLMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.26% yearly.
EPS Next Y8.13%
EPS Next 2Y2.92%
EPS Next 3Y10.75%
EPS Next 5Y14.19%
Revenue Next Year4.26%
Revenue Next 2Y5.41%
Revenue Next 3Y4.96%
Revenue Next 5Y4.26%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HLMN Yearly Revenue VS EstimatesHLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
HLMN Yearly EPS VS EstimatesHLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1

5

4. Valuation

4.1 Price/Earnings Ratio

HLMN is valuated correctly with a Price/Earnings ratio of 14.46.
HLMN's Price/Earnings ratio is rather cheap when compared to the industry. HLMN is cheaper than 83.59% of the companies in the same industry.
When comparing the Price/Earnings ratio of HLMN to the average of the S&P500 Index (27.30), we can say HLMN is valued slightly cheaper.
A Price/Forward Earnings ratio of 13.65 indicates a correct valuation of HLMN.
Based on the Price/Forward Earnings ratio, HLMN is valued a bit cheaper than the industry average as 78.91% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of HLMN to the average of the S&P500 Index (21.76), we can say HLMN is valued slightly cheaper.
Industry RankSector Rank
PE 14.46
Fwd PE 13.65
HLMN Price Earnings VS Forward Price EarningsHLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

78.91% of the companies in the same industry are more expensive than HLMN, based on the Enterprise Value to EBITDA ratio.
69.53% of the companies in the same industry are more expensive than HLMN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.92
EV/EBITDA 9.86
HLMN Per share dataHLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

HLMN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.78
PEG (5Y)N/A
EPS Next 2Y2.92%
EPS Next 3Y10.75%

0

5. Dividend

5.1 Amount

HLMN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HILLMAN SOLUTIONS CORP

NASDAQ:HLMN (7/8/2025, 8:00:01 PM)

After market: 7.5 -0.02 (-0.27%)

7.52

+0.13 (+1.76%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners103.41%
Inst Owner Change0.01%
Ins Owners1.12%
Ins Owner Change5.74%
Market Cap1.49B
Analysts78.57
Price Target10.93 (45.35%)
Short Float %3.07%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.25%
Min EPS beat(2)-7.7%
Max EPS beat(2)1.2%
EPS beat(4)2
Avg EPS beat(4)0.8%
Min EPS beat(4)-7.7%
Max EPS beat(4)11.6%
EPS beat(8)5
Avg EPS beat(8)8.75%
EPS beat(12)9
Avg EPS beat(12)35.03%
EPS beat(16)11
Avg EPS beat(16)166.29%
Revenue beat(2)0
Avg Revenue beat(2)-1.78%
Min Revenue beat(2)-2.16%
Max Revenue beat(2)-1.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.92%
Min Revenue beat(4)-3.55%
Max Revenue beat(4)-0.57%
Revenue beat(8)0
Avg Revenue beat(8)-2.52%
Revenue beat(12)0
Avg Revenue beat(12)-2.85%
Revenue beat(16)2
Avg Revenue beat(16)-1.93%
PT rev (1m)0%
PT rev (3m)-14.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.81%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.45%
Valuation
Industry RankSector Rank
PE 14.46
Fwd PE 13.65
P/S 1
P/FCF 17.92
P/OCF 8.69
P/B 1.26
P/tB N/A
EV/EBITDA 9.86
EPS(TTM)0.52
EY6.91%
EPS(NY)0.55
Fwd EY7.32%
FCF(TTM)0.42
FCFY5.58%
OCF(TTM)0.87
OCFY11.51%
SpS7.5
BVpS5.98
TBVpS-1.2
PEG (NY)1.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.79%
ROE 1.56%
ROCE 4.18%
ROIC 2.72%
ROICexc 2.76%
ROICexgc 8.92%
OM 5.91%
PM (TTM) 1.24%
GM 47.9%
FCFM 5.59%
ROA(3y)-0.11%
ROA(5y)-0.56%
ROE(3y)-0.26%
ROE(5y)-2.17%
ROIC(3y)1.94%
ROIC(5y)1.62%
ROICexc(3y)1.97%
ROICexc(5y)1.64%
ROICexgc(3y)6.76%
ROICexgc(5y)6%
ROCE(3y)2.98%
ROCE(5y)2.49%
ROICexcg growth 3Y110.94%
ROICexcg growth 5Y37.21%
ROICexc growth 3Y112.78%
ROICexc growth 5Y43.98%
OM growth 3Y102.86%
OM growth 5Y36.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.57%
GM growth 5Y2.32%
F-Score7
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 8.77
Debt/EBITDA 3.23
Cap/Depr 66.13%
Cap/Sales 5.95%
Interest Coverage 1.94
Cash Conversion 77.46%
Profit Quality 449.74%
Current Ratio 2.46
Quick Ratio 0.79
Altman-Z 1.58
F-Score7
WACC9.12%
ROIC/WACC0.3
Cap/Depr(3y)59.2%
Cap/Depr(5y)51.21%
Cap/Sales(3y)4.97%
Cap/Sales(5y)4.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y8.13%
EPS Next 2Y2.92%
EPS Next 3Y10.75%
EPS Next 5Y14.19%
Revenue 1Y (TTM)0.31%
Revenue growth 3Y1.08%
Revenue growth 5Y3.93%
Sales Q2Q%2.58%
Revenue Next Year4.26%
Revenue Next 2Y5.41%
Revenue Next 3Y4.96%
Revenue Next 5Y4.26%
EBIT growth 1Y14.99%
EBIT growth 3Y105.05%
EBIT growth 5Y41.6%
EBIT Next Year150.04%
EBIT Next 3Y40.67%
EBIT Next 5Y26.22%
FCF growth 1Y5.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.97%
OCF growth 3YN/A
OCF growth 5Y28.46%